Clinical Efficacy of Pretransplant Vaccination for Preventing Herpes Zoster After Living Donor Liver Transplantation in Recipients Age 50 Years and Older

BACKGROUND: There have been no reports concerning the efficacy of pretransplant herpes zoster (HZ) vaccination following living donor liver transplantation (LDLT). MATERIAL/METHODS: From January 2013 to May 2016, 24 patients age 50 years and older received vaccination of HZ prior to transplantation...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Chan Woo, Kim, Jong Man, Choi, Gyu-Seong, Joh, Jae-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484871/
https://www.ncbi.nlm.nih.gov/pubmed/30992423
http://dx.doi.org/10.12659/AOT.914213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484871/
https://www.ncbi.nlm.nih.gov/pubmed/30992423
http://dx.doi.org/10.12659/AOT.914213

Ejemplares similares